NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/08/2024
Back to search
Official data from USPTO
TISSUECYTE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
03/08/2024
Classification
Registered
Trademark type
Word
Nice classes
9
Filing date
06/06/2012
Registration date
09/24/2013
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/08/2024
Last transaction
03/08/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
02/28/2011
First use in commerce
02/28/2011
Drawing code
4
Owner type
03
Owner location
Cambridge, MA, US
Examiner
MARTIN, JENNIFER
Law office
M70
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
TissueVision, Inc.
Representatives
Thomas O. Hoover, Esq. MCCARTER & ENGLISH, LLP
Technical classification
Nice Classes
Class 9
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Microscopes and microscope accessories, software for operating microscopes
Publications
History of USPTO decisions and trademark events.
27 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
03/08/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/08/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/08/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
09/25/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
09/24/2022
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
11/03/2019
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/03/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/03/2019
E815
TEAS SECTION 8 & 15 RECEIVED
09/24/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
09/24/2013
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
08/20/2013
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
08/19/2013
ALIE
ASSIGNED TO LIE
08/19/2013
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/07/2013
SUPC
STATEMENT OF USE PROCESSING COMPLETE
07/22/2013
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/22/2013
IUAF
USE AMENDMENT FILED
06/27/2013
EISU
TEAS STATEMENT OF USE RECEIVED
06/27/2013
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
01/01/2013
PUBO
PUBLISHED FOR OPPOSITION
11/06/2012
NPUB
NOTICE OF PUBLICATION
10/17/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/26/2012
DOCK
ASSIGNED TO EXAMINER
09/23/2012
MPMK
NOTICE OF PSEUDO MARK MAILED
06/16/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/15/2012
NWAP
NEW APPLICATION ENTERED
06/09/2012
Continuous trademark protection
Get notified about every new filing that threatens TISSUECYTE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.